FDA clears Novavax’s fall booster for Covid-19, weeks after mRNA vaccine boosters
The FDA cleared Novavax’s updated Covid-19 booster for the fall season on Tuesday, weeks after mRNA boosters secured an authorization.
Novavax made clear last month that doses had arrived in the US and were ready to ship. However, regulators made no mention of the booster in a Sept. 11 announcement clearing updated shots from both Pfizer/BioNTech and Moderna.
At the time, a Novavax spokesperson said the company was “currently responding to the FDA’s requests to facilitate final review.” Shares of Novavax stock rose 11% on Tuesday following the EUA.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.